BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andreev DN, Maev IV, Dicheva DT. Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for Helicobacter pylori Infection: Meta-Analysis of Randomized Controlled Studies. J Clin Med 2019;8:E1498. [PMID: 31546909 DOI: 10.3390/jcm8091498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang LG, Lu ZZ, Yang L, Liu HY, Cai LL. Efficacy of traditional Chinese medicine as adjunctive treatment for Helicobacter pylori: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2020; 28(5): 172-183 [DOI: 10.11569/wcjd.v28.i5.172] [Reference Citation Analysis]
2 Nishizawa T, Munkjargal M, Ebinuma H, Toyoshima O, Suzuki H. Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review. J Clin Med 2021;10:2722. [PMID: 34202993 DOI: 10.3390/jcm10122722] [Reference Citation Analysis]
3 Hou D, Yang M, Hu Z, Yang L. Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20620. [PMID: 32569191 DOI: 10.1097/MD.0000000000020620] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Maev IV, Andreev DN, Govorun VM, Ilina EN, Kucheryavyy YA, Oganesian TS, Melnikova EV, Zayratyants OV, Parfenova TV, Dzhedzheia LV, Kirillova NV, Maevskaya EA, Fomenko AK, Lobanova EG, Zaborovskii AV, Kriukov KA. [Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results]. Ter Arkh 2020;92:24-8. [PMID: 33346458 DOI: 10.26442/00403660.2020.08.000761] [Reference Citation Analysis]
5 Ivashkin VT, Trukhmanov AS, Gonik MI. Rebamipide using in gastroesophageal reflux disease treatment. Terapevticheskii arkhiv 2020;92:98-104. [DOI: 10.26442/00403660.2020.04.000568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
6 Bordin DS, Voynovan IN, Embutnieks YV, Nyssen OP, Megraud F, O`morain C, Perez-gisbert J. European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow. Terapevticheskii arkhiv 2020;92:12-8. [DOI: 10.26442/00403660.2020.02.000567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Andreev DN, Maev IV. [Rebamipide: evidence base for use in gastroenterology]. Ter Arkh 2020;92:97-104. [PMID: 33720581 DOI: 10.26442/00403660.2020.12.200455] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ivashkin VT, Maev IV, Tsar’kov PV, Korolev MP, Andreev DN, Baranskaya EK, Burkov SG, Derinov AA, Efetov SK, Lapina TL, Pavlov PV, Pirogov SS, Tkachev AV, Trukhmanov AS, Fedorov ED, Sheptulin AA. Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:49-70. [DOI: 10.22416/1382-4376-2020-30-1-49-70] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
9 Martynov AI, Sheptulin AA, Mayev IV, Kazyulin AN, Karateev AY, Melekhov AV, Pal’gova LK, Raikhel’son KL. New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:7-14. [DOI: 10.22416/1382-4376-2020-30-2-7-14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]